Economist Podcasts
Orexins are peptides involved in the body’s sleep-wake system—and are big pharma’s next big thing. Like multi-purpose GLPs, they may have far more uses [https://www.economist.com/science-and-technology/2026/08/11/the-brain-may-be-about-to-have-its-ozempic-moment?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners] than just regulating shuteye. We ask why Japan’s post-war innovation boom petered out, and what must be done to breed more unicorns [https://www.economist.com/business/2026/08/13/japans-downbeat-startups-need-a-lift?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners]. And why procrastination seems to be on the rise, and how to beat it [https://www.economist.com/science-and-technology/2026/07/31/how-to-stop-procrastinating?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners]. Guests and host: * Shailesh Chitnis, global business correspondent * Ethan Wu, Asia business and finance editor * Benjamin Sutherland, science writer * Rosie Blau, co-host of “The Intelligence” * Jason Palmer, co-host of “The Intelligence” Topics covered: * orexins, peptides, sleep disorders, pharmaceuticals * Japan, innovation, startups * procrastination Listen to what matters most, from global politics and business to science and technology—subscribe to The Economist [https://subscribenow.economist.com/podcasts-plus]. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.
300 jaksot
Kommentit
0Ole ensimmäinen kommentoija
Rekisteröidy nyt ja liity Economist Podcasts-yhteisöön!